The silencing of RECK gene is associated with promoter hypermethylation and poor survival in hepatocellular carcinoma

International Journal of Biological Sciences

Volumn 8, Issue 4, 2012, Pages 451-458

  Zhang, Changsong ^a,b,d   Ling, Yang ^a   Zhang, Chenghui ^c   Xu, Yun ^c   Gao, Lu ^b   Li, Rong ^b   Zhu, Jing ^a   Fan, Lieying ^d   Wei, Lixin ^b  

^a SOOCHOW UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c Department of Oncology   (China)

^d TONGJI UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Methylation; RECK

Indexed keywords

GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; RECK PROTEIN, HUMAN;

ARTICLE; CELL STRAIN HEPG2; DNA METHYLATION; GENE SILENCING; GENETICS; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DNA METHYLATION; GENE SILENCING; GPI-LINKED PROTEINS; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84863233381     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.4038     Document Type: Article

References (24)

1. Clark JC, Thomas DM, Choong PF, Dass CR. RECK--a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer. Cancer Metastasis Rev. 2007; 26: 675-683. doi:10.1007/s10555-007-9093-8.
2. Noda M, Takahashi C, Matsuzaki T, Kitayama H. What we learn from transformation suppressor genes: lessons from RECK. Future Oncol. 2010; 6: 1105-1116. doi:10.2217/fon.10.80.
3. Takenaka K, Ishikawa S, Yanagihara K, Miyahara R, Hasegawa S, Otake Y, et al. Prognostic significance of reversion-inducing cysteine-rich protein with Kazal motifs expression in resected pathologic stage IIIA N2 non-small-cell lung cancer. Ann Surg Oncol. 2005; 12: 817-824. doi:10.1245/ASO.2005.09.018.
4. van der Jagt MF, Sweep FC, Waas ET, Hendriks T, Ruers TJ, Merry AH, et al. Correlation of reversion-inducing cysteine-rich protein with kazal motifs (RECK) and extracellular matrix metalloproteinase inducer (EMMPRIN), with MMP-2, MMP-9, and survival in colorectal cancer. Cancer Lett. 2006; 237: 289-297. doi:S0304-3835(05)00554-9 [pii] 10.1016/j.canlet.2005.06.009.
5. Masui T, Doi R, Koshiba T, Fujimoto K, Tsuji S, Nakajima S, et al. RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis. Clin Cancer Res. 2003; 9: 1779-1784.
6. Song SY, Son HJ, Nam E, Rhee JC, Park C. Expression of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) as a prognostic indicator in gastric cancer. Eur J Cancer. 2006; 42: 101-108. doi:S0959-8049(05)00871-3 [pii] 10.1016/j.ejca.2005.09.016.
7. Li SL, Gao DL, Zhao ZH, Liu ZW, Zhao QM, Yu JX, et al. Correlation of matrix metalloproteinase suppressor genes RECK, VEGF, and CD105 with angiogenesis and biological behavior in esophageal squamous cell carcinoma. World J Gastroenterol. 2007; 13: 6076-6081.
8. Span PN, Sweep CG, Manders P, Beex LV, Leppert D, Lindberg RL. Matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs: a prognostic marker for good clinical outcome in human breast carcinoma. Cancer. 2003; 97: 2710-2715. doi:10.1002/cncr.11395.
9. Namwat N, Puetkasichonpasutha J, Loilome W, Yongvanit P, Techasen A, Puapairoj A, et al. Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases. J Gastroenterol. 2011; 46: 664-675. doi:10.1007/s00535-010-0345-y.
10. Rodriguez-Paredes M, Esteller M. Cancer epigenetics reaches mainstream oncology. Nat Med. 2011; 17: 330-339. doi:nm.2305 [pii] 10.1038/nm.2305.
11. Chang HC, Cho CY, Hung WC. Down regulation of RECK by promoter methylation correlates with lymph node metastasis in non-small cell lung cancer. Cancer Sci. 2007; 98: 169-173. doi:CAS367 [pii] 10.1111/j.1349-7006.2006.00367.x.
12. Long NK, Kato K, Yamashita T, Makita H, Toida M, Hatakeyama D, et al. Hypermethylation of the RECK gene predicts poor prognosis in oral squamous cell carcinomas. Oral Oncol. 2008; 44: 1052-1058. doi:S1368-8375(08)00048-1 [pii] 10.1016/j.oraloncology.2008.02.004.
13. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol. 2001; 35: 421-430.
14. Zhang C, Xu Y, Zhao J, Fan L, Jiang G, Li R, et al. Elevated expression of the stem cell marker CD133 associated with Line-1 demethylation in hepatocellular carcinoma. Ann Surg Oncol. 2011; 18: 2373-2380. doi:10.1245/s10434-011-1599-1.
15. Cho CY, Wang JH, Chang HC, Chang CK, Hung WC. Epigenetic inactivation of the metastasis suppressor RECK enhances invasion of human colon cancer cells. J Cell Physiol. 2007; 213: 65-69. doi:10.1002/jcp.21089.
16. Bais AJ, Gardner AE, McKenzie OL, Callen DF, Sutherland GR, Kremmidiotis G. Aberrant CBFA2T3B gene promoter methylation in breast tumors. Mol Cancer. 2004; 3: 22. doi:10.1186/1476-4598-3-22 1476-4598-3-22 [pii].
17. Zhang C, Guo X, Zhang L, Lu Z, Ma N, Cheng Y, et al. Methylation-related silencing of p14ARF gene correlates with telomerase activity and mRNA expression of human telomerase reverse transcriptase in hepatocellular carcinoma. J Surg Oncol. 2008; 98: 462-468. doi:10.1002/jso.21131.
18. Simizu S, Takagi S, Tamura Y, Osada H. RECK-mediated suppression of tumor cell invasion is regulated by glycosylation in human tumor cell lines. Cancer Res. 2005; 65: 7455-7461. doi:65/16/7455 [pii] 10.1158/0008-5472.CAN-04-4446.
19. Sasahara RM, Brochado SM, Takahashi C, Oh J, Maria-Engler SS, Granjeiro JM, et al. Transcriptional control of the RECK metastasis/angiogenesis suppressor gene. Cancer Detect Prev. 2002; 26: 435-443.
20. Ferguson LR, Tatham AL, Lin Z, Denny WA. Epigenetic regulation of gene expression as an anticancer drug target. Curr Cancer Drug Targets. 2011; 11: 199-212. doi:EPub-Abstract-CCDT-102 [pii].
21. Kato K, Long NK, Makita H, Toida M, Yamashita T, Hatakeyama D, et al. Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells. Br J Cancer. 2008; 99: 647-654. doi:6604521 [pii] 10.1038/sj.bjc.6604521.
22. Chang HC, Cho CY, Hung WC. Silencing of the metastasis suppressor RECK by RAS oncogene is mediated by DNA methyltransferase 3b-induced promoter methylation. Cancer Res. 2006; 66: 8413-8420. doi:66/17/8413 [pii] 10.1158/0008-5472.CAN-06-0685.
23. Liu LT, Chang HC, Chiang LC, Hung WC. Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion. Cancer Res. 2003; 63: 3069-3072.
24. Jeon HW, Lee YM. Inhibition of histone deacetylase attenuates hypoxia-induced migration and invasion of cancer cells via the restoration of RECK expression. Mol Cancer Ther. 2010; 9: 1361-1370. doi:1535-7163.MCT-09-0717 [pii] 10.1158/1535-7163.MCT-09-0717.